CaHA Injectable for Facial Use Gains Regulatory Approval in China
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
The approval makes it the first calcium hydroxylapatite microsphere injectable product approved in China for facial soft tissue augmentation, according to the company.
Research published in the Journal of Cosmetic Dermatology highlights the stability and skin-mimicking properties of lipid-soluble vitamin C derivatives.